AI-generated summary
The authors report a randomized, triple-blind, placebo-controlled trial of photobiomodulation applied 8 to 12 hours after total hip arthroplasty in 18 patients, split into active and placebo groups of nine. In the active group, pain scores and serum TNF-α and IL-8 levels decreased compared with placebo, while IL-6 did not change. The authors conclude the treatment is effective for pain and inflammation, though the sample is small.
- Participants
- 18
- Who or what was studied
- Patients who underwent total hip arthroplasty for hip osteoarthritis
- Wavelengths
- 905, 875, 640 nm
- Limits stated in the abstract
- The trial had a small sample of 18 patients, divided into two groups of nine, and measured only immediate effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 905 nm, 875 nm, 640 nm
- Total energy
- 40.3 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Inflammation, Photobiomodulation, Placebo-controlled, Low-level laser therapy, Laser, Visual analogue scale, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.